OCD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with OCD for at least 5 years.
- Your OCD has been rated as severe or extreme by a medical professional.
- You have tried at least 3 SSRI medications (a common type of antidepressant used for OCD) and a medication called clomipramine, and they have not helped enough.
- Your main OCD symptom is not hoarding.
- You have completed, or genuinely attempted to complete, a type of therapy called Exposure and Response Prevention (ERP).
- You do not have a serious additional psychiatric condition (such as a personality disorder) or current problems with substance misuse.
- You meet the medical requirements to have a device called a deep brain stimulator surgically implanted.
- You are 18 years old or older.
- You have not previously had surgery to remove or destroy the specific area of the brain that this trial targets.
- You are not currently pregnant.
- You do not have any other neurological (brain or nervous system) conditions, including dementia.
- You do not have a bleeding disorder and are not taking blood-thinning medications.
- You are able to understand and agree to the trial terms and give your own informed consent.
Who may not be able to join:
- You are unable to operate the neurostimulator device (the implanted device used in this treatment) by yourself.
- You are likely to be exposed to a type of heat therapy called diathermy (a treatment sometimes used in physiotherapy — confirm with trial site if you are unsure whether this applies to you).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Albert J Fenoy, MD, Northwell Health
Phone: 7184704152
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Efficacy as indicated by a decrease in obsessive compulsive symptoms as assessed by the Yale-Brown Obsessive Compulsive Scale (Y-BOCS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.